|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02348 DAWNRAYS PHARMA
Nominal 
1.080 -0.050 (-4.425%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -- | 14.805% | 8.937% | 10.212% | 11.474% |
| ROAE (%) | -- | 18.286% | 11.862% | 14.258% | 15.740% |
| Return on Capital Employed (%) | -- | 16.353% | 11.037% | 13.065% | 13.555% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | -- | 54.477% | 55.729% | 60.543% | 58.470% |
| EBITDA Margin (%) | -- | 67.382% | 44.646% | 42.868% | 44.982% |
| Pre-tax Profit Margin (%) | -- | 60.072% | 35.969% | 34.313% | 37.705% |
| Net Profit Margin (%) | -- | 53.281% | 28.320% | 28.024% | 30.741% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | -- | 3.971 X | 2.572 X | 1.871 X | 2.168 X |
| Quick Ratio (X) | -- | 3.415 X | 2.256 X | 1.612 X | 1.876 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | -- | 17.026% | 21.074% | 27.849% | 28.198% |
| Total Debt / Total Assets (%) | -- | 0.866% | 3.327% | 0.229% | 0.704% |
| Net Debt / Total Assets (%) | -- | -14.490% | -6.799% | -21.872% | -16.596% |
| Total Debt / Shareholders' Funds (%) | -- | 1.044% | 4.222% | 0.318% | 0.988% |
| Long Term Debt / Shareholders' Funds (%) | -- | 0.111% | 0.004% | 0.017% | 0.064% |
| Net Debt / Shareholders' Funds (%) | -- | -17.476% | -8.628% | -30.404% | -23.280% |
| Net Cash / (Debt) ($) | -- | 580.956M | 246.299M | 803.270M | 554.224M |
| Net Cash / (Debt) per share ($) | -- | 0.387 | 0.164 | 0.536 | 0.370 |
| Total Debt / Capital Employed (%) | -- | 1.005% | 4.081% | 0.307% | 0.890% |
| Interest Coverage Ratio (X) | -- | 177.538 X | 419.662 X | 1182.693 X | 686.371 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | -- | 196.364 Day | 162.169 Day | 161.174 Day | 169.530 Day |
| Receivables Turnover (Day) | -- | 101.530 Day | 114.915 Day | 107.074 Day | 106.122 Day |
| Payables Turnover (Day) | -- | 66.046 Day | 61.233 Day | 52.462 Day | 47.119 Day |
| Remarks: | Real time quote last updated: 30/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 213,971 |
| %Change | -62.125% |
| EPS / (LPS) | RMB 0.140 |
| NBV Per Share (¥) | RMB -- |